Related Experiment Video
Updated: Jan 4, 2026

Author Spotlight: Exploring the Relationship Between Lipotoxicity and HFpEF
Published on: March 29, 2024
Hypocholesterolemia in cats: a multicenter retrospective study of 106 cats
Claudia Bowman1, Austin Viall2, Adam Rudinsky3
1VCA Care Specialty and Emergency Animal Hospital, Santa Barbara, CA, USA.
Insights
Hypocholesterolemia in cats is linked to gastrointestinal, liver, blood, and urinary diseases. While low cholesterol alone doesn't affect survival, combined with low albumin, it indicates a poorer prognosis for feline patients.
Area of Science:
- Veterinary Internal Medicine
- Feline Health
- Clinical Pathology
Background:
- Hypocholesterolemia, or low cholesterol, is an uncommon finding in cats.
- Associated diseases and prognostic factors in hypocholesterolemic cats are not well-defined.
Purpose of the Study:
- To describe clinicopathologic findings in hypocholesterolemic cats.
- To identify diseases associated with low cholesterol in cats.
- To evaluate prognostic factors in this population.
Main Methods:
- Retrospective review of medical records from two veterinary referral centers (2004-2016).
- Inclusion criteria: serum cholesterol below the reference interval.
- Clinicopathologic data and survival to discharge were analyzed.
Main Results:
- 106 hypocholesterolemic cats were identified, with a median age of 6 years.
- Most common associated diseases: gastrointestinal (25.9%), hepatobiliary (19.8%), hematologic (14.8%), and urogenital (14.8%).
- Concurrent hypoalbuminemia significantly increased the risk of non-survival (OR 15.6).
Conclusions:
- Hypocholesterolemia in cats is frequently associated with serious underlying diseases.
- The degree of hypocholesterolemia did not impact survival.
- The combination of hypocholesterolemia and hypoalbuminemia is a negative prognostic indicator in cats.
Objectives:
The aim of this study was to describe the clinicopathologic findings and associated diseases found in a population of hypocholesterolemic cats referred to two tertiary care facilities.
Methods:
An electronic medical record search was performed at two veterinary university referral centers to identify cats with serum cholesterol values below the reference interval between January 2004 and 2016. Clinicopathologic data were reviewed for each case and cats were classified into specific disease categories based on clinical diagnosis. Median cholesterol values were compared between disease categories, as well as between survivors and non-survivors.
Results:
In total, 106 hypocholesterolemic cats were included. The median age of the cats was 6 years (range 0.24-18 years). The most common disease categories were gastrointestinal (25.9%), hepatobiliary (19.8%), hematologic (14.8%) and urogenital (14.8%). Though median serum cholesterol values did not differ significantly between survivors and non-survivors, cats with concurrent hypoalbuminemia were at higher risk (odds ratio 15.6, 95% confidence interval 5.2-46.6; P <0.0001) of not surviving to discharge than cats with normal serum albumin concentrations.
Conclusions And Relevance:
Taken together, our data suggest that while the degree of hypocholesterolemia did not appear to influence survival rates, the concurrent presence of hypocholesterolemia and hypoalbuminemia was associated with a worse prognosis.
Related Concept Videos
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Blood Studies for Cardiovascular System III: Serum Lipid Profile
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Hypertension III: Clinical Manifestations and Diagnostic Studies
Cholesterol: Significance and Regulation
Considering cholesterol and...
Atherosclerosis III: Management

